Related Experiment Videos
Myasthenia gravis during interferon alfa therapy
A P Batocchi1, A Evoli, S Servidei
1Institute of Neurology, Catholic University, Rome, Italy.
Neurology
|February 1, 1995
Abstract:
Patients treated with interferon alfa can develop autoantibodies and autoimmune diseases. We describe two patients who developed myasthenia gravis with abnormal levels of serum anti-acetylcholine receptor antibodies during interferon alfa-2b treatment for malignancies. One of these patients had myopathic findings on EMG and focal deficiency of cytochrome c oxidase on muscle biopsy.